Clinical significance of anti-β2-glycoprotein I antibodies

Annales de Medecine Interne

Volumn 147, Issue SUPPL. 1, 1996, Pages 15-17

  Amengual, Olga ^a   Atsumi, Tatsuya ^a   Khamashta, Munther A ^a   Hughes, Graham R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIGENICITY; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; THROMBOSIS;

EID: 0029814193     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. MCNEIL HP, SIMPSON RJ, CHESTERMAN CN, KRILIS SA : Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation; β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990 ; 87 : 4120-4.
2. GALLI M, CONFURIUS P, MAASSEN C et al : Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990 ; 335 : 1544-51.
3. MATSUURA E, IGARASHI Y, FUJIMOTO M, ICHIKAWA K, KOIKE T : Anticardiolipin cofactor (s) and differential diagnosis of autoimmune disease. Lancet 1990 ; 336 : 177-8.
4. BEVERS EM, GALLI M, BARBUI T et al : Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991 ; 66 : 629-32.
5. SUGI T, MCINTYRE JA : Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995 ; 86 : 3083-9.
6. ROUBEY RAS : Autoantibodies to phospholipid-binding plasma proteins : a new view of lupus anticoagulants and other " antiphospholipid " autoantibodies. Blood 1994 ; 84 : 2854-67.
7. HUNT JE, KRILIS SA : The fifth domain of β2-glycoprotein I contains a phospholipid binding site (Cys 281-Cys 288) and a region recognized by anticardiolipin antibodies. J Immunol 1994 ; 152 : 653-9.
8. LOZIER J, TAKAHASHI N, PUTNAN FW : Complete amino acid sequence of human β2-glycoprotein I. Proc Natl Acad Sci USA 1984 ; 81 : 3640-4.
9. SHOUSBOE I : β2-glycoprotein I : plasma inhibitor of contact activation of the intrinsic blood coagulation pathway. Blood 1985 ; 66 : 1086-91.
10. SCHOUSBOE I, RASMUSSEN MS : Synchronized inhibition of phospholipid mediated autoactivation of factor XII in plasma by β2-glycoprotein I and anti-β2-glycoprotein I. Thromb Haemost 1995 ; 73 : 798-804.
11. SHI W, CHONG B, HOGG P et al : Anticardiolipin antibodies block the inhibition of the factor Xa generating activity of platelets. Thromb Haemost 1993 ; 70 : 342-5.
12. NIMPF J, BEVERS EM, BOMANS PHH, TILL U, WURM H, KOSTNER GM, ZAWAAL RFA : Prothrombinase activity of human platelets is inhibited by β2-glycoprotein I. Biochem Biophys Acta 1986 ; 884 : 142-49.
13. NIMPF J, WURM H, KOSTNER GM : Interaction of β2-glycoprotein I with human blood platelets : influence upon the ADP induced aggregation. Thromb Haemost 1985 ; 54 : 397-401.
14. MORI T, TAKEYA H, NISHIOKA J, GABAZZA EC, SUZUKI N : β2-glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb Haemost 1996 ; 75 : 49-55.
15. MATSUURA E, IGARASHI Y, YASUDA T, TRIPLETT D, KOIKE T : Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface J Exp Med 1994 ; 179 : 457-62.
16. ROUBEY RAS, EISENBERG RA, HARPER MF, WINFIELD JB : Anticardiolipin antibodies recognize β2-glycoprotein I in the absence of phospholipids. J Immunol 1995 ; 154 : 954-60.
17. PERMPIKUL P, RAO LV, RAPAPORT SI : Functional and binding studies of the roles of prothrombin and β2-glycoprotein I in the expression of lupus anticoagulant activity Blood 1994 ; 83 : 2878-92.
18. Sorice M, Circella A, Griggi T et al : Anticardiolipin and anti β2-GPI are two distinct population of autoantibodies. Thromb Haemost 1996 ; 75 : 393-8.
19. CABIEDES J, CABRAL AR, ALARCON SEGOVIA D : Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti β2-glycoprotein I that with anti-phospholipid antibodies. J Rheum 1995 ; 22 : 1899-906.
20. MARTINUZZO ME, FORASTIERO RR, CARRERAS LO : Anti-β2-Glycoprotein I antibodies : detection and association with thrombosis. B J Haematol 1995 ; 89 : 397-402.
21. AMENGUAL O, ATSUMI T, KHAMASHTA MA, HUGHES GRV : Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphospholipid syndrome. Arthritis Rheum 1995 ; 38 : 109 (abstract).
22. HARRIS EN, GHARAVI AE, BOEY ML et al : Anticardiolipin antibodies : detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983 ; ii : 1211-4.
23. HUNT JE, MCNEIL HP, MORGAN GJ, CRAMERI RM, KRILIS SA : A phospholipid β2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992 ; 1 : 83-90.
24. ARVIEUX J, ROUSSEL B, JACOB MC, COLOMB MG : Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as a antigen. J Immunol Meth 1991 ; 143 : 223-9.
25. LOVE PE, SANTORO SA : Antiphospholipid antibodies : anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non- SLE disorders. Ann Intern Med 1990 ; 112 : 682-98.
26. ALARCON SEGOVIA D, DELEZE M, ORIA CV et al : Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989 ; 68 : 353-65.
27. HARRIS EN, CHAN JKN, ASHERSON RA et al : Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986 ; 146 : 2153-6.
28. CERVERA R, KHAMASHTA MA, FONT J et al : Systemic lupus erythematosus : clinical and immunological patterns of disease expression in a cohort of 1000 patients. Medicine 1993 ; 72 : 113-24.